Skip to main content
. 2021 May 1;11(5):414. doi: 10.3390/life11050414

Table 6.

Clinical and demographic characteristics of patients with CV risk according to the presence or absence of atherosclerotic plaques.

Without Plaque (n = 64) With Plaque (n = 234) p
Sex (male) 36 (53) 175 (76) 0.32
Age (years) 63 (55–76) 67 (60–76) 0.15
BMI (kg/m2) 27.3 (25.7–30.4) 28.6 (26.1–32.0) 0.13
Abdominal perimeter (cm) 101.5 ± 13.6 104.0 ± 11.1 0.13
Hypertension (yes) 50 (73.5) 165 (71.7) 0.64
Diabetes (yes) 23 (33.8) 96 (41.7) 0.28
Dyslipidaemia (yes) 49 (72.1) 193 (83.9) 0.07
Systolic BP (mmHg) 135.6 ± 18.3 136.3 ± 19 0.77
Diastolic BP (mmHg) 77.6 ± 13.3 79.1 ± 13.9 0.43
HbA1c (%) 5.7 (5.4–6.3) 5.7 (5.5–6.3) 0.81
Cholesterol (mg/dL) 168 (147–203) 169 (148–198) 0.74
HDL-C (mg/dL) 55 (39–67) 50 (42–62) 0.71
LDL-C (mg/dL) 94 (70–127) 91 (72–120) 0.52
Triglycerides (mg/dL) 98 (70–130) 108 (78–149,5) 0.16
Creatinine (mg/dL) 1 (0.8–1.18) 1 (0.8–1) 0.8
Smoking (yes) 9 (13.2) 38 (16.5) 0.51
Alcohol (yes) 7 (10.3) 45 (6.5) 0.08
PREDIMED score 9 (8–10) 9 (7–10) 0.98
SDF1 (ng/mL) 2.5 ± 0.9 2.5 ± 0.7 0.85
MMP12 a (pg/mL) 381 (228–591) 424 (261–666) 0.11
CRP a (mg/dL) 0.18 (0.07–0.54) 0.17 (0.08–0.4) 0.16

Continuous parametric variables are shown as mean (standard deviation), non-parametric as median (Interquartile range) and qualitative variables as number (%). a Logarithmically transformed. BMI: Body mass index, BP: Blood pressure, HbA1c: Glycosylated haemoglobin, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol, PREDIMED: PREvencion con DIeta MEDiterranea, SDF1: Stromal derived factor 1, MMP12: Matrix metalloproteinase 12, CRP: C-reactive protein.